General Information of This Payload
Payload ID
PAY0FAGJB
Name
Glucuronide-dPBD
Synonyms
Glucuronide-dPBD
   Click to Show/Hide
Target(s) Human Deoxyribonucleic acid (hDNA)
Structure
Formula
C51H61N5O19
Isosmiles
C=C1CC2C(O)Nc3cc(OCCCCCOc4cc5c(cc4OC)C(=O)N4CC(=C)CC4C(O)N5C(=O)OCc4ccc(OC5OC(C(=O)O)C(O)C(O)C5O)c(C(=O)NCCOC)c4)c(OC)cc3C(=O)N2C1
InChI
InChI=1S/C51H61N5O19/c1-25-15-33-45(61)53-31-20-38(36(69-4)18-28(31)46(62)54(33)22-25)71-12-7-6-8-13-72-39-21-32-29(19-37(39)70-5)47(63)55-23-26(2)16-34(55)48(64)56(32)51(67)73-24-27-9-10-35(30(17-27)44(60)52-11-14-68-3)74-50-42(59)40(57)41(58)43(75-50)49(65)66/h9-10,17-21,33-34,40-43,45,48,50,53,57-59,61,64H,1-2,6-8,11-16,22-24H2,3-5H3,(H,52,60)(H,65,66)
InChIKey
OUXGYUFKVWKDMM-UHFFFAOYSA-N
Pharmaceutical Properties
Molecule Weight
1048.065
Polar area
314.35
Complexity
75
xlogp Value
1.7396
Heavy Count
75
Rot Bonds
19
Hbond acc
19
Hbond Donor
8
The activity data of This Payload
Standard Type Value Units Cell line Disease Model Cell line ID Reference
Half Maximal Inhibitory Concentration (IC50) 0.003±0.001 nmol/L
HEL 92.1.7 cells
Erythroleukemia
CVCL_2481 
[1]
Half Maximal Inhibitory Concentration (IC50) 0.005±0.001 nmol/L
HL-60 cells
Adult acute myeloid leukemia
CVCL_0002 
[1]
Half Maximal Inhibitory Concentration (IC50) 0.006±0.002 nmol/L
TF-1 cells
Esophageal squamous cell carcinoma
CVCL_1759 
[1]
Half Maximal Inhibitory Concentration (IC50) >1000 nM
MKN45 cells
Gastric adenocarcinoma
CVCL_0434 
[2]
Half Maximal Inhibitory Concentration (IC50) >1000 nM
EBC-1 cells
Lung squamous cell carcinoma
CVCL_2891 
[2]
Each Antibody-drug Conjugate Related to This Payload
References
Ref 1 Development of Highly Optimized Antibody-Drug Conjugates against CD33 and CD123 for Acute Myeloid Leukemia. Clin Cancer Res. 2021 Jan 15;27(2):622-631.
Ref 2 cIRCR201-dPBD, a Novel Pyrrolobenzodiazepine Dimer-Containing Site-Specific Antibody-Drug Conjugate Targeting c-Met Overexpression Tumors. ACS Omega. 2020 Sep 29;5(40):25798-25809.

If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.